Health Care: Drugs

Puma Biotechnology Inc (PBYI: NYSE)

$230.05 0.87 | 0.38%
11/26/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 229.18
52 Week High 279.37
52 Week Low 45.94
Avg. Daily Vol. (Mil) 0.28
Beta (3 year) -2.40
Share Related Items
Mkt Cap (Mil) 6,909.33
Shares Out (Mil) 30.15
Float (Mil) 20.23
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.30
Current Ratio 5.50
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 48.79
Price/Cash Flow -62.90
Per Share Data
Earnings -3.70
Sales 0.00
Book Value 4.70
Cash Flow -3.64
Business Summary
Puma Biotechnology Inc is a development-stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer.
General Information
10880 Wilshire Boulevard
Suite 2150
Los Angeles, CA 90024
www.pumabiotechnology.com
Industry : Drugs
Sector: Health Care
Employees: 72
CEO: Alan H. Auerbach
Short Interest
Current Month (Mil) 1.94
Previous Month (Mil) 1.86
Short Interest Ratio (Days) 6.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -64.20
Return on Investments -78.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with PBYI

Latest PBYI Headlines from TheStreet

More Financial News for PBYI

Press Releases for PBYI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter